We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

26 hedge funds and large institutions have $16.2M invested in Cardiff Oncology in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

986% more call options, than puts

Call options by funds: $76K | Put options by funds: $7K

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

18% more funds holding

Funds holding: 22 → 26 (+4)

2% more capital invested

Capital invested by funds: $15.9M → $16.2M (+$273K)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
7
Closed
1
Calls
$76K
Puts
$7K
Net Calls
+$69K
Net Calls Change
+$69K

Top Buyers

1
MWVC
Morgens Waterfall Vintiadis & Co
New York
+$1.69M
2
DADC
D.A. Davidson & Co
Montana
+$333K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$74.5K
4
NPC
National Planning Corporation
California
+$22.3K
5
BA
BlackRock Advisors
Delaware
+$16.8K

Top Sellers

1
CWG
C WorldWide Group
Denmark
-$366K
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$336K
3
Morgan Stanley
Morgan Stanley
New York
-$206K
4
PP
Paloma Partners
Connecticut
-$59K
5
TRCT
Tower Research Capital (TRC)
New York
-$17.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
26
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 -$10K -31 -94%
PP
27
Paloma Partners
Connecticut
– -$59K -178 Closed
1
2